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HSP: Helper, suppressor, protector
Competent emergency care depends on a coordinated
and cooperative team approach. In “real life,” the patient
benefits most from immediate basic life support on site
and highly specialized treatment of his specific injuries
thereafter. The former can be provided by well-trained
laymen and only a few tools are needed; the latter de-
pends on specialists and high-tech equipment.
Novel technologies such as microarray and proteomic
analyses have taught us that survival of “molecular emer-
gencies” also depends on complex interactions between
different cellular processes and pathways. In that regard,
heat-shock proteins (HSP) can be regarded as the perfect
molecular providers of basic life support for the injured
cell protein machinery.
HSP, mostly grouped in families according to their
molecular weight, are found throughout the cell, and the
amount of all isoforms can constitute up to 5% of total
cellular proteins [1]. HSP are rapidly induced by a vari-
ety of cellular stressors, such as heat, UV light, or cyto-
toxic agents. All these inducers of HSP have in common
that they are proteotoxic or proteochaotic, resulting in
increased cellular levels of denatured proteins [2]. The
most accepted hypothesis currently is that under control
conditions the constitutive transcription factor HSF is in-
hibited by constitutive HSP. Increased levels of disrupted
and denatured proteins compete for the binding of HSP
and thereby initiate the activation of HSF, resulting in
increased transcription of HSP genes [1, 2]. Whereas the
role of HSP during cellular repair processes remains to be
fully elucidated, constitutively expressed members of the
best-studied HSP families are known to bind to nascent
and immature proteins and prevent premature and im-
proper binding and folding [1]. More recently, HSP have
been shown to interact with signal transducers involved
in active cell death, suppressing apoptotic pathways [3].
With regard to our emergency situation analogy, HSP
most likely correspond to nonspecialized laymen with
strong arms and limited but broadly applicable tools. Like
good rescuers, HSP thrive on chaos and set out to “help”
disrupted proteins, “suppress” active cell death pathways,
and thus “protect” the cell.
Extremely high and fluctuating interstitial osmolali-
ties in the renal medulla are physicochemical conditions
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that perfectly represent a physiologically relevant pro-
teochaotic injury model [4, 5]. Indeed, the “life threaten-
ing environment” in the renal medulla has been shown
to result in increased local abundance of renal tubu-
lar HSP in in vivo experimental models [6, 7]. Using
well-controlled in vitro systems, an essential role of the
70 kD HSP (HSP-72) has subsequently been demon-
strated for cellular survival against such extreme con-
ditions. Pre-exposure of various medullary derived cell
lines to different stressful environments resulted in sig-
nificant increases of HSP-72 expression, and markedly
improved survival when cells underwent a repeat expo-
sure [7, 8]. Such findings of increased resistance to repeat
cellular injury are called cytoprotection and the treat-
ment resulting in this cytoprotection is termed condition-
ing. More recently, Neuhofer et al [9] provided more di-
rect evidence by showing that selective overexpression
of HSP-72 via transfection resulted in improved survival
of treated cells in media mimicking “lethal” conditions
in the renal medulla. Moreover, targeted disruption of
the tonicity-inducible HSP-72 genes in mice resulted in
induced apoptosis in renal papillary cells upon hyperos-
motic challenge [10].
In this issue of Kidney International, Neuhofer et al
take an important step to transfer their in vitro findings
back into the in vivo model, choosing an indirect yet el-
egant way to demonstrate protective effects of HSP-72.
They treated rats with rofecoxib and showed that inhibi-
tion of COX-2 was associated with significantly reduced
expression of HSP-72 in the renal medulla. Upon wa-
ter deprivation, the animals with COX-2 pretreatment
(= with decreased HSP-72 expression) exhibited signif-
icantly increased indices of apoptosis (caspase3 activity
and TUNEL stain) compared with nontreated control
animals. The authors then confirmed their results in vitro
using the IMCD3 cell line. Again, COX-2 inhibition
resulted in both decreased HSP-72 expression and in-
creased cellular death following exposure to high urea
concentrations. Using this in vitro system, the authors also
demonstrated that a COX-2 dependent prostaglandin
(12-PGJ2) induced HSP-72 and conferred cytoresis-
tance against hypertonicity. Therefore, Neuhofer et al
conclude that COX-2 inhibition suppresses HSP-72 ex-
pression and thus increases susceptibility of papillary cells
to high solute concentrations during water deprivation
via reduced synthesis of cytoprotectant prostaglandins.
Neuhofer’s study not only provides insight into new
aspects of renal toxicity of COX-2 inhibition, it is one of
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the few studies on HSP that does not set out to give too
simple answers to complex questions. Although the cyto-
protective role of HSP has been demonstrated in several
other clinically relevant injury models, the essential step
from bench to bedside for HSP-mediated cytoprotection
has not as yet been successful.
Many issues relevant to HSP mediated protection re-
main, such as the search for the most important HSP (if
there is one), or how to target and dose HSP expression
to clinical benefit. However, we regard it as doubtful that
extreme selective overexpression of any given HSP will
ever achieve major therapeutic effects in complex injury
or disease models. If we accept the initial analogy be-
tween “real life” and “molecular” emergency situations,
this should come as no major surprise. Modern physicians
readily accept that the survival of a victim depends on
an integrated interdisciplinary approach. Similarly, HSPs
might be essential to confer help, suppression, and protec-
tion during or immediately after an unforeseen molecular
catastrophe. But why should 100 additional paramedics
really improve the outcome of 5 injured victims who have
already been stabilized and now await brain surgery? In-
deed, effects of experimental overexpression of HSP are
most impressive in simple assays, measuring live/death
outcome upon lethal exposure to heat or different modal-
ities of energy depletion at the single cell level or in primi-
tive whole organism. Whereas such straightforward over-
expression or suppression of HSP might suffice to alter
outcome in simple biologic models, more sophisticated
approaches are needed in models that are more complex
and clinically relevant.
With regards to Neuhofer’s current study [11], it is rea-
sonable to accept that the early outcome of the medullary
cell will depend on competent molecular basic life sup-
port, in part provided by HSP. In due course, highly
specialized cellular reactions must take over and deal
with the specific physicochemical conditions in the re-
nal papilla during antidiuresis, such as high interstitial
solute concentrations, low interstitial pO2 and pH. COX-
2 is involved in complex cellular reactions, and its inhi-
bition will involve multiple early as well as delayed re-
sponses against these otherwise lethal physicochemical
conditions. The effects on HSP-mediated cytoprotection
via altered prostaglandin synthesis likely represents only
one of these pathways [12]. However, albeit indirectly,
Neuhofer described for the first time that the level of HSP
expression in vivo predicted the medullary cell outcome
during hyperosmotic challenge during water deprivation.
One may speculate that for any given “molecular emer-
gency situation” in vivo, a certain minimal amount of HSP
is essential for cellular outcome, and that suppression of
HSP below this threshold, such as with COX-2 inhibition
or other pharmacologic manipulations, will likely turn out
to be detrimental.
Will HSP ever be introduced in clinical medicine as a
successful therapeutic tool [13]? We certainly think so.
However, the stress researcher may have to take a step
back to carefully dissect complex injury models in order
to define specific pathologic processes that can be pos-
itively influenced by HSPs. HSP might then represent
prime candidates for clinical situations associated with
acute predictable insults such as organ procurement in
transplant medicine, protocol toxic drug exposure in on-
cology, or repetitive exposure to hyperosmolar and aci-
dotic peritoneal dialysis fluids [14, 15].
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